CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Kedrion : à l'ESID 2026, les experts appellent à un diagnostic plus précoce et à une meilleure sensibilisation face à l'augmentation continue des déficits immunitaires secondaires

ConferenceNeutral
AI Analysis

Summary

Kedrion participated in ESID 2026 conference in Maastricht where experts discussed the need for earlier diagnosis and increased awareness of secondary immunodeficiency disorders, which are becoming more prevalent with increased use of immunosuppressive therapies.

Importance:2/10
Sentiment:
0.00
immunodeficiencysecondary immunodeficiencyclinical awarenessESID 2026diagnostics

Read the original article

Published by PR Newswire Biotech on October 14, 2026 3:29 PM

Read Original